Organogenesis Holdings Inc (NASDAQ: ORGO) is -6.72% lower on its value in year-to-date trading and has touched a low of $2.28 and a high of $6.71 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ORGO stock was last observed hovering at around $3.06 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $2.98, the stock is -34.38% and -36.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.29 million and changing -2.45% at the moment leaves the stock -16.42% off its SMA200. ORGO registered 29.22% gain for a year compared to 6-month gain of -7.01%.
The stock witnessed a -20.40% loss in the last 1 month and extending the period to 3 months gives it a -16.39%, and is -43.89% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.08% over the week and 9.23% over the month.
Organogenesis Holdings Inc (ORGO) has around 869 employees, a market worth around $378.65M and $458.76M in sales. Fwd P/E is 19.90. Profit margin for the company is -4.06%. Distance from 52-week low is 30.92% and -55.51% from its 52-week high. The company has generated returns on investments over the last 12 months (-4.64%).
The EPS is expected to grow by 650.00% this year.
Organogenesis Holdings Inc (ORGO) Top Institutional Holders
The shares outstanding are 126.85M, and float is at 64.40M with Short Float at 18.28%.
The top institutional shareholder in the company is MORGAN STANLEY with over 11.58 million shares valued at $32.41 million. The investor’s holdings represent 8.7318% of the ORGO Shares outstanding. As of 2024-06-30, the second largest holder is SOLEUS CAPITAL MANAGEMENT, L.P. with 11.52 million shares valued at $32.25 million to account for 8.6888 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.09 million shares representing 3.8372% and valued at over $14.24 million, while ASSENAGON ASSET MANAGEMENT S.A. holds 2.9999 of the shares totaling 3.98 million with a market value of $11.14 million.
Organogenesis Holdings Inc (ORGO) Insider Activity
#####
Organogenesis Holdings Inc disclosed in a document filed with the SEC on Mar 04 ’25 that Driscoll Michael Joseph (Director) sold a total of 25,000 shares of the company’s common stock. The trade occurred on Mar 04 ’25 and was made at $5.10 per share for $0.13 million. Following the transaction, the insider now directly holds 0.17 million shares of the ORGO stock.
Still, SEC filings show that on Dec 13 ’24, Gillheeney Gary S. (President and CEO) disposed off 55,615 shares at an average price of $3.36 for $0.19 million. The insider now directly holds 3,044,779 shares of Organogenesis Holdings Inc (ORGO).
